CausalSentinel

Protein Dossier — CD300C (CMRF35-like molecule 6)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Coronary heart disease -0.0838 0.0199 2.44e-05 Inverse variance weighted 2 cis NA
Coronary heart disease -0.0838 0.0199 2.44e-05 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: hypertension 0.0321 0.00785 4.43e-05 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: hypertension 0.0321 0.00785 4.43e-05 Inverse variance weighted 2 trans NA
Myocardial infarction -0.0861 0.0227 1.53e-04 Inverse variance weighted 2 cis NA
Myocardial infarction -0.0861 0.0227 1.53e-04 Inverse variance weighted 2 trans NA
Age at menopause 0.16 0.0599 0.00766 Wald ratio 1 trans NA
Body fat -0.0315 0.0126 0.0121 Wald ratio 1 trans NA
HOMA-B 0.0184 0.00778 0.0183 Wald ratio 1 trans NA
HOMA-IR 0.022 0.00938 0.0193 Wald ratio 1 trans NA
Diastolic blood pressure automated reading 0.0113 0.00487 0.0201 Inverse variance weighted 2 cis NA
Diastolic blood pressure automated reading 0.0113 0.00487 0.0201 Inverse variance weighted 2 trans NA
…and 156 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5066_134_3 CLM6 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

8 association rows across 8 traits (5 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Cerebrospinal fluid protein CD300C levels 3e-253 rs2293188 1 GCST90944162 no MR -> candidate analysis
Circulating CD300C levels 9e-102 rs924828 1 GCST90859659 no MR -> candidate analysis
CD300E protein levels 6e-20 rs56095552 1 GCST90468621 no MR -> candidate analysis
CMRF35-like molecule 6 levels 2e-17 rs73359962 1 GCST90059929 no MR -> candidate analysis
CD300C protein levels 1e-14 rs144088488 1 GCST90468620 no MR -> candidate analysis
Velopharyngeal dysfunction 2e-6 rs931791 1 GCST006280 no MR -> candidate analysis
Baseline memory in impaired cognition x sex interaction 5e-6 rs113310167 1 GCST90448440 no MR -> candidate analysis
Parkinson’s disease motor subtype (tremor to postural instab 9e-6 rs118076379 1 GCST90000015 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 82 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
diabetes mellitus 0.207 common-variant locus no MR -> candidate analysis

Of the 1 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.0066, LOEUF=0.989 — LoF-tolerant
GWAS Catalog 81 unique SNPs / 162 rows
ClinVar 77 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance